Core and Main Inc vs Eli Lilly And Co — how do they compare? Core and Main Inc trades at $44.74 (market cap $8.46B), while Eli Lilly And Co trades at $1,143.98 (market cap $1.03T). The key difference: Eli Lilly And Co is far larger — about 121.7× Core and Main Inc's market cap, and Eli Lilly And Co pays a 0.6% dividend while Core and Main Inc pays none. Which is the better fit depends on your goals.
| CNM | LLY | |
|---|---|---|
Market Cap | $8.46B | $1.03T |
Sector | Technology | Health |
52-Week High | $66.98 | $1.24K |
52-Week Low | $44.29 | $625.65 |
Enterprise Value | $10.76B | $1.07T |
Dividend Yield | — | 0.6% |
Signals from Pluang's Aura AI — not financial advice
Core & Main (CNM) trades at $44.74, down 2.44% today, amid bearish technical signals but strong fundamentals. The stock shows consistent earnings beats, with Q1 2026 EPS of $0.72 exceeding expectations, and maintains solid profitability with a 23.73% ROE. Recent news highlights municipal strength and margin gains, though residential segments face weakness. Cash flow trends improved in 2026 projections, with net cash flow rising to $142M from $7M in 2025.
The outlook is mixed: analyst consensus leans bullish with 57% buy ratings, but technical indicators signal near-term pressure. Key risks include industry headwinds like high operating costs and residential market softness. Investors should weigh strong fundamentals against current bearish momentum for entry timing.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Core & Main is a leading US distributor of water, wastewater, storm drainage, and fire protection products. It provides essential infrastructure solutions to municipalities, private water companies, and contractors.
Read more on CNM →Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →